Triple-negative breast cancer (TNBC) is a highly invasive and intractable breast cancer subtype characterized by a lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER 2) [1]. This evidence concerns the gene ESR1 and breast cancer.